Viewing Information

Getting Started

To fully participate in this online program you must be registered and logged in. Read all the information presented below. When ready select the "View Program" tab above.

Claiming CME/CE Credits

To receive CME/CE credits, participants must review the program materials in their entirety and complete the online post examination and evaluation with a score of 75% or better.

System Hardware/Software and Internet Connection Requirements

The following information is provided for your reference in conjunction with review of this program.

General System and Internet Requirements: Speakers or Headphones, High Speed Internet connection, Wireless 3G and 4G,
Web browsers: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher and Chrome.

Operating Systems: Windows 2000 or higher, (MS Surface and other MS mobile devices compatible), MAC OSX 10.3 or higher, Mac iOS 5.0 or higher (iPad, iPhone compatible), Android 4.3 or higher (most Android mobile devices compatible).

Program Summary

In this second in a 3 Part Series, Dr. Laurie Fajardo discusses the benefits of digital breast tomosynthesis (DBT) for detecting and diagnosing breast cancer and things to consider when planning or implementing DBT into breast imaging practices.

Dr. Fajardo discusses the importance of radiation dose reduction with synthetic 2D, reviews the published literature on the performance of synthetic 2D mammography, and shares how DBT can impact data storage and network data transmission across your PACS and enterprise system.

CME Effective Date: October 13, 2020
CME Expiration Date: October 31, 2022

CE Effective Date: October 13, 2020
CE Expiration Date: October 31, 2022

Format: Self Instructional - Audio Visual with Slides
Educational Credits:
One (1) AMA/PRA Category 1 CME Credit™
One (1) ARRT Category A CE Credit.
One (1) AHRA CRA Credit
Estimated Completion Time: 1 hour

This program is supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.

Target Audience & Cost

This program is intended for: Radiologists, Other MD's, Radiologic Technologists, Radiology Administrators and related Imaging Professionals.

There is no cost to participate in this program.

Educational Objectives

Upon completion of this CME activity the healthcare provider should be able to:

Describe the efficacy of synthetic 2D from DBT.
Implement procedures for managing DBT data volumes and workflow.
Develop an approach to interpreting DBT images.

No special educational preparation is required for this CME/CE Activity!

Presented by

Laurie L. Fajardo, MD, MBA, FACR, FSBI
Department of Radiology and Imaging Sciences
University of Utah School of Medicine
Salt Lake City, Utah

Laurie Fajardo, MD, MBA, FACR, FSBI is a Professor of Radiology at the University of Utah. Her research efforts have focused on all aspects of breast imaging including new methods and applications of digital technologies, most recently DBT and phase contrast breast imaging. Her contributions to science include the development and clinical evaluation of Stereotactic Breast Biopsy, Digital Mammography, DBT and Phase I testing of 2D and 3D Phase Contrast Breast Imaging.

Conflict of Interest Disclosure Policy

IAME requires everyone who is in a position to control the content of a CE/CME activity to disclose all relevant financial relationships with any commercial interest. This information is utilized to 1) determine if a conflict exists, 2) resolve the conflict by initiating a content validation process, and 3) advise learners of this information. Any individual who refuses to (or chooses not to) disclose relevant financial relationships will be disqualified from participating as an instructor, planner or manager and cannot have control of or responsibility for the development, management, presentation or evaluation of a CE/CME activity certified by IAME.

Disclosures

Laurie L. Fajardo, MD, MBA, FACR, FSBI, discloses she has had a consulting relationship with FUJIFILM Medical Systems U.S.A., Inc.

No one at the Institute for Advanced Medical Education (IAME) or who has control of this activity has financial relationships with commercial supporters.

Accreditation

The Institute for Advanced Medical Education (IAME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Institute for Advanced Medical Education (IAME) designates this enduring material for a maximum of 1.0 AMA/PRA Category 1 CME Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.

Radiologic Technologists:
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for One (1) ARRT Category A CE Credit.

Radiology Administrators:
This course meets all CRA renewal credit criteria and has been approved for One (1) continuing education credit in the following CRA domains: Asset Resource Management (AM) and Operations Management (OM).

For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.

Method of Participation/Criteria for Success

CME Credits
To receive CME credits for participating in this CME activity you must successfully complete the online post examination with a passing score of 70% or higher.

CE Credits
To receive CE credits for participating in this CE activity you must successfully complete the online post examination with a passing score of 80% or higher.

Online examinations return an immediate grade report. Upon receiving a passing score click Continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate button displayed from within your MyAR Archives page.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Important Viewing Information

To begin, place your mouse over the presentation area and click the play button. To pause the presentation, place your mouse over the presentation and click the screen. To start the program, click the screen again. To advance or rewind, place your mouse over the screen to display the control bar. Once displayed, click and drag the play bar to the right to advance and to the left to rewind. To start from desired point, click the screen or play button.

Please Note: For best results this program should be viewed on a high speed internet connection. If viewing on a network and/or device with limited bandwidth; the quality of the audio and/or video may be altered. These are items which are beyond our control and as such; we recommend viewing these programs on a high speed WiFi or direct network connection.

1. Friedewald SM, et al. Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography. JAMA 2014;311(24):2499‐2507

2. Ciatto et al. Integration of 3D Digital Mammography with Tomosynthesis for Population Breast‐Cancer Screening (STORM): A Prospective Comparison Study. Lancet Oncology 2013;14:583‐589

3. Skanne et al. Comparison of Digital Mammography Alone and Digital Mammography Plus Tomosynthesis in a Population‐based Screening Program. Radiology 2013;267:47‐56

4. Skanne et al. Radiology 2019;291:23‐30

5. Rosenberg RD, et al. Performance benchmarks for screening mammography. Radiology 2006;241(1):55‐66. doi:10.1148/radiol.2411051504

6. ACR BI‐RADS Atlas, Breast Imaging Reporting and Data System. American College of Radiology. 5th Edition, 2013

7. Lehman CD, et al. National performance benchmarks for modern screening digital mammography: update from the Breast Cancer Surveillance Consortium. Radiology 2017;283(1):49‐58. doi.10.1148/radiol.2016161174

8. Melnikow J, Fenton JJ. Digital Breast Tomosynthesis – Diffusion into Practice Preceding Evidence. JAMA Intern Med 2019;179(9):1295‐1296

9. Dodelzon yet al. Performance of 2D Synthetic Mammography Versus Digital Mammography in the Detection of Microcalcifications at Screening. AJR 2020;214:1‐9

10. Bae et al. Microcalcifications Detected at Screening MG: S‐2D & DBT versus DM. Radiology 2018;289:630‐638

11. Hofvind et al. DBT & s‐2D MG vs. DM: Evaluation in a population‐based screening program. Radiology 2018;287(3):787‐794

12. Aujero et al. Clinical Performance of s‐2D MG combined with DBT in a large screening population. Radiology 2017;283(1); 70‐76

13. Zuckerman et al. Implementation of s‐2D MG in a Population‐Based DBT screening program. Radiology 2016;281(3):730‐736

Part 2 | The Application of Integrating DBT Into Your Practice